Pfizer Inc. has decided to stop the development of its obesity pill, danuglipron, after safety concerns emerged from a clinical trial. This move comes as competition heats up with Novo Nordisk and Eli Lilly's successful weight-loss treatments.
As A.D.H.D. diagnoses soar, new research raises critical questions about how we define and treat this complex condition. Discover the latest findings that could reshape our understanding of A.D.H.D.
Meghan Trainor opens up about her weight-loss journey, revealing the medication and lifestyle changes that helped her transform after two pregnancies. Discover the secrets behind her stunning transformation!
A groundbreaking blood test developed by researchers may change how Alzheimer's is diagnosed and treated, providing insights into the disease's progression and helping identify suitable medications.
In this article, we explore the portrayal of lorazepam in 'The White Lotus' and its implications for mental health awareness. Insights from Dr. Gail Saltz reveal the dangers and realities of this commonly prescribed medication.
Novo Nordisk's diabetes pill Rybelsus has shown significant cardiovascular benefits, reducing the risk of heart-related issues by 14%. This could offer a new, convenient treatment option for many patients.
Discover the surprising findings from a global review on effective treatments for lower back pain. From exercise to medication, learn what truly works to alleviate your discomfort and improve your quality of life.
Briana Adesso, a 31-year-old teacher, faced sudden weight gain and health issues due to hypothyroidism and insulin resistance. Discover her journey to lose 50 pounds with medication and a healthy lifestyle.
A groundbreaking daily pill for endometriosis has been approved for NHS use, allowing women to manage symptoms effectively at home. This first-of-its-kind treatment replaces multiple medications and clinic visits.
A groundbreaking study from Washington University reveals that new Alzheimer’s medications could extend patient independence by up to 13 months. Discover how these findings reshape treatment decisions.
